- Home
- MVBF vs NMRA Comparison
MVBF vs NMRA Comparison
Compare MVBF & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | MVBF | NMRA |
|---|---|---|
| Founded | 1997 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 371.6M | 302.0M |
| IPO Year | 2004 | 2023 |
Fundamental Metrics
Financial Performance| Metric | MVBF | NMRA |
|---|---|---|
| Price | $30.62 | $1.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 8 |
| Target Price | ★ $29.50 | $7.50 |
| AVG Volume (30 Days) | 47.3K | ★ 702.3K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.63% | N/A |
| EPS Growth | ★ 34.64 | 5.23 |
| EPS | ★ 1.32 | N/A |
| Revenue | ★ $3,400,000.00 | N/A |
| Revenue This Year | $1.70 | N/A |
| Revenue Next Year | $13.59 | N/A |
| P/E Ratio | $22.92 | ★ N/A |
| Revenue Growth | ★ 51.92 | N/A |
| 52 Week Low | $23.72 | $0.83 |
| 52 Week High | $31.99 | $3.65 |
Technical Indicators
Market Signals| Indicator | MVBF | NMRA |
|---|---|---|
| Relative Strength Index (RSI) | 51.75 | 41.22 |
| Support Level | $27.21 | $0.83 |
| Resistance Level | $30.22 | $1.77 |
| Average True Range (ATR) | 0.73 | 0.11 |
| MACD | -0.08 | -0.03 |
| Stochastic Oscillator | 53.63 | 23.75 |
Price Performance
Historical ComparisonAbout MVBF MVB Financial Corp.
MVB Financial Corp is a financial holding company. The company provides a wide range of business activities through the Bank, commercial and retail banking services, as well as Fintech banking. It has three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of its revenue is generated from the CoRe Banking segment, which includes its Fintech division, represents banking products and services offered to customers by the Bank, loans and deposits accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.